Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in PCD pharma franchise in Hyderabad

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharmaceutical manufacturing company in Mumbai

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in antibiotic pharma franchise in Pune

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharma suppliers in Delhi

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharma export companies in Kolkata
Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharma franchise opportunities in Bengaluru

Home/Products /amoxycillin-potassium-clavulanate-mg-dry-syrup

Moxyplit ES Dry Syrup

Composition : Amoxycillin (600 mg) + Potassium Clavulanate (42.9 mg) dry syrup

Dosage Form : Dry Syrup

Packaging Type : Vial + Water

Packaging : 50 ml

Price : ₹243/-

Moxyplit ES Dry Syrup is a pediatric oral formulation combining Amoxycillin (600mg), a broad-spectrum penicillin antibiotic, with Potassium Clavulanate (42.9mg), a β-lactamase inhibitor. This powerful combination enhances the efficacy of amoxycillin by protecting it from degradation by β-lactamase-producing bacteria. The syrup is effective against a wide range of bacterial infections commonly affecting children, including respiratory tract infections, otitis media, sinusitis, and urinary tract infections. The extended-spectrum (ES) formulation ensures potent antibacterial action with convenient dosing for better compliance in pediatric care.

Read More

About the Product

Moxyplit ES Dry Syrup is a pediatric oral formulation combining Amoxycillin (600mg), a broad-spectrum penicillin antibiotic, with Potassium Clavulanate (42.9mg), a β-lactamase inhibitor. This powerful combination enhances the efficacy of amoxycillin by protecting it from degradation by β-lactamase-producing bacteria. The syrup is effective against a wide range of bacterial infections commonly affecting children, including respiratory tract infections, otitis media, sinusitis, and urinary tract infections. The extended-spectrum (ES) formulation ensures potent antibacterial action with convenient dosing for better compliance in pediatric care.

Common side effects may include diarrhea, nausea, vomiting, or mild skin rash. Some children may experience abdominal discomfort or allergic reactions. Severe allergic responses or persistent gastrointestinal symptoms should be promptly reported to a doctor.

Moxyplit ES Dry Syrup is indicated for the treatment of pediatric bacterial infections, such as acute otitis media, sinusitis, pneumonia, bronchitis, tonsillitis, and urinary tract infections, especially when caused by β-lactamase-producing strains resistant to amoxycillin alone.

This medication should be used only under the supervision of a pediatrician. Complete the prescribed course even if symptoms improve early. Shake well before each use. Not effective against viral infections. Reconstitution instructions must be followed carefully.

Store the dry syrup bottle in a cool, dry place below 25°C, away from sunlight. After reconstitution with boiled and cooled water, keep refrigerated (2°C to 8°C) and use within 7 days. Discard any remaining syrup after this period. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation